Both in Pharmaceuticals
BridgeBio Pharma vs Jazz Pharmaceuticals
Over the past year BBIO returned +24.0% and JAZZ returned +67.0%; their daily moves had a correlation of 0.19.
BBIO +24.0% JAZZ +67.0%Growth of $1, one year, split-adjusted
| Metric | BBIO | JAZZ |
|---|---|---|
| Price | $76.83 | $231.15 |
| Market cap | $14.97B | $15.01B |
| Today | +3.78% | +0.61% |
| 1 month | +14.7% | −0.1% |
| 6 months | +12.8% | +1.1% |
| Year to date | +0.4% | +36.0% |
| 1 year | +24.0% | +67.0% |
| Revenue growth (YoY) | +192.6% | +10.4% |
| Gross margin | 94.2% | 91.1% |
| Net margin | −23.5% | −38.9% |
| P/E (TTM) | — | 72.9× |
| Price / sales | 15.8× | 3.2× |
| Net cash | -$938.6M | -$2.71B |
| Dividend yield | — | — |
| Volatility (60d) | 33.3% | 30.9% |
| Short % of float | 12.5% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).